Lepadin H
Lepadin H is a ferroptosis inducer and apoptosis inducer with in vitro cytotoxicity and in vivo antitumor efficacy against cancer cells. Lepadin H reduces GPX4 and SLC7A11 levels, increases p53 and ACSL4 expression, drives lipid hydroperoxide production, elevates reactive oxygen species (ROS) levels, reduces cellular glutathione (GSH) levels, induces lipid peroxidation and G2/M phase cell cycle arrest, and suppresses clonogenic growth and migration of cancer cells.Lepadin H can be used for the research of melanoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 412328-25-7
- Formel: C26H45NO3
- Molecular Weight:419.64
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
ACSL4 |
GPX4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
4.68 μM
Compound: Lepadin H
|
Cytotoxicity against human A549 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human A549 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| B16-F10 | IC50 |
3.14 μM
Compound: Lepadin H
|
Cytotoxicity against mouse B16-F10 cells incubated for 72 hrs by MTT assay
Cytotoxicity against mouse B16-F10 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| HeLa | IC50 |
2.52 μM
Compound: Lepadin H
|
Cytotoxicity against human HeLa cells incubated for 72 hrs by MTT assay
Cytotoxicity against human HeLa cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| HepG2 | IC50 |
6.2 μM
Compound: Lepadin H
|
Cytotoxicity against human HepG2 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| L02 | IC50 |
12.49 μM
Compound: Lepadin H
|
Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| MCF7 | IC50 |
5.03 μM
Compound: Lepadin H
|
Cytotoxicity against human MCF7 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| MDA-MB-231 | IC50 |
8.51 μM
Compound: Lepadin H
|
Cytotoxicity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| NCI-H1155 | IC50 |
7.06 μM
Compound: Lepadin H
|
Cytotoxicity against human NCI-H1155 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H1155 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| NCI-H1355 | IC50 |
9.3 μM
Compound: Lepadin H
|
Cytotoxicity against human NCI-H1355 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H1355 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| SH-SY5Y | IC50 |
5.8 μM
Compound: Lepadin H
|
Cytotoxicity against human SH-SY5Y cells incubated for 72 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| SK-OV-3 | IC50 |
8.02 μM
Compound: Lepadin H
|
Cytotoxicity against human SK-OV-3 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human SK-OV-3 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
| SMMC-7721 | IC50 |
4.09 μM
Compound: Lepadin H
|
Cytotoxicity against human SMMC-7721 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human SMMC-7721 cells incubated for 72 hrs by MTT assay
|
[PMID: 37578947] |
In Vitro
Lepadin H (72 h) potently inhibits the viability of 10 human cancer cell lines and 1 normal human cell line (L02) with IC50 values ranging from 2.52 μM (HeLa) to 12.49 μM (L02) after 72 h incubation[1].
Lepadin H (5-9 μM; 24 h) inhibits clonogenic growth of HeLa cells in a dose-dependent manner, with complete inhibition at 8 and 9 μM after 24 h treatment[1].
Lepadin H (0.625-10 μM; 24 h) potently suppresses HeLa cell migration in a dose-dependent manner when treated for 24 h at concentrations from 0.625 to 10 μM[1].
Lepadin H (4-10 μM; 24 h) induces dose-dependent apoptosis in HeLa cells, with ~70% apoptotic cells at 10 μM after 24 h treatment, and upregulates cleaved-PARP expression[1].
Lepadin H (4-12 μM; 24 h) causes dose-dependent G2/M phase cell cycle arrest in HeLa cells and upregulates p53 and p21 protein expression after 24 h treatment[1].
Lepadin H (6-20 μM; 0.5-1 h) increases intracellular ROS levels in HeLa cells in a dose- and time-dependent manner[1].
Lepadin H (10-12 μM; 4 h) significantly increases lipid peroxidation in HeLa cells, with ~55% and ~73% lipid peroxidation observed at 10 and 12 μM after 4 h treatment, respectively[1].
Lepadin H (2.5-20 μM; 24 h) induces ferroptosis in HeLa cells via the p53-SLC7A11-GPX4 pathway, as evidenced by reduced GSH levels, characteristic mitochondrial ultrastructural changes, upregulated ACSL4 expression, downregulated SLC7A11 and GPX4 expression[1].
Lepadin H (6 μM; 24 h) alters the transcriptome and proteome of HeLa cells, with significant enrichment of ferroptosis-related pathways and downregulation of ferroptosis-associated gene SLC7A11[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa
-
Concentration:5 μM, 6 μM, 7 μM, 8 μM, 9 μM
-
Incubation Time:24 h
-
Result:Completely eliminated colony formation at 8 and 9 μM.
Strongly reduced colony numbers at 7 μM.
Showed partial inhibition of colony growth at 5 and 6 μM compared to control.
-
Cell Line:HeLa
-
Concentration:0.625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM
-
Incubation Time:24 h
-
Result:Significantly inhibited cell migration at all tested concentrations in a dose-dependent manner.
Showed the strongest inhibition at 10 μM.
-
Cell Line:HeLa
-
Concentration:4 μM, 6 μM, 8 μM, 10 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in ~70% of cells at 10 μM.
Induced dose-dependent increase in apoptotic cell percentages at 4, 6, 8, and 10 μM.
Markedly increased cleaved-PARP protein levels at 10 μM.
-
Cell Line:HeLa
-
Concentration:4 μM, 6 μM, 8 μM, 10 μM, 12 μM
-
Incubation Time:24 h
-
Result:Induced dose-dependent G2/M phase cell cycle arrest with increasing percentages of cells in G2/M phase at 4 to 12 μM.
Upregulated p53 and p21 protein levels in a dose-dependent manner at 4, 6, 8, and 10 μM.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (female, 8 weeks old, subcutaneous injection of 1 × 107 B16F10 cells)[1]
-
Dosage:30 mg/kg
-
Administration:i.p.; daily; 14 consecutive days
-
Result:Reduced tumor volume from ~1500 mm3 to <500 mm3 (a greater than three-fold reduction).
Significantly decreased tumor weight relative to controls.
Showed no significant changes in mouse body weight, organ indexes, or histologic tissue damage in heart, liver, spleen, lung, kidney, or thymus.
Chemical Information
-
CAS. Nr. 412328-25-7
-
Molecular Weight 419.64
-
Formel C26H45NO3
-
SMILES
CCC[C@@H](O)CCCC[C@@H]1[C@@]2([H])[C@](CCC1)([H])N[C@H]([C@@H](C2)OC(/C=C/C=C/CCC)=O)C
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Patient-Derived Xenograft (PDX)
Patient-derived xenograft (PDX) models are generated by engrafting primary human tumor tissue directly into immunodeficient mice, allowing in vivo propagation of patient tumor biology without initial in vitro adaptation. These models are used to preserve key histopathological and molecular characteristics of the original tumor and enable assessment of tumor growth dynamics and therapeutic response in a living organism. The biological readout is tumor engraftment and subsequent growth in the murine host, which reflects the ability of human tumor cells to survive, vascularize, and expand in an immunocompromised microenvironment.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Lepadin H
- 412328-25-7
- Ferroptosis
- Apoptosis
- ACSL Family
- Glutathione Peroxidase
- Reactive Oxygen Species (ROS)
- ferroptosis
- melanoma
- tumor protein p53
- apoptosis
- acyl-CoA synthetase long chain family member 4
- HeLa
- reactive oxygen species
- solute carrier family 7 member 11
- glutathione peroxidase 4
- lipid peroxidation
- Inhibitor
- inhibitor
- inhibit